Modified FOLFOX6 plus bevacizumab with and without nivolumab for first-line treatment of metastatic colorectal cancer: phase 2 results from the CheckMate 9X8 randomized clinical trial
改良版FOLFOX6方案联合贝伐珠单抗(加或不加纳武利尤单抗)一线治疗转移性结直肠癌:CheckMate 9X8随机临床试验的II期结果
期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2023-008409
Lenz, Heinz-Josef; Parikh, Aparna; Spigel, David R; Cohn, Allen L; Yoshino, Takayuki; Kochenderfer, Mark; Elez, Elena; Shao, Spencer H; Deming, Dustin; Holdridge, Regan; Larson, Timothy; Chen, Eric; Mahipal, Amit; Ucar, Antonio; Cullen, Dana; Baskin-Bey, Edwina; Kang, Tong; Hammell, Amy B; Yao, Jin; Tabernero, Josep